I just wanted to send out an update to everyone interested in the HCMC-VA-UMN clinical trial, which we have named E-STAND (Epidural STimulation After Neurologic Damage). We have been granted FDA approval to move forward and are hopefully just days away from final approval at our first site, Hennepin County Medical Center.
We are excited to get started and busy preparing. Once we have IRB approval, we will send out specific information about how to sign up for screening and how to refer patients. We will have an active presence on a new website, where the trial will be more clearly described.
I know that everyone is anxiously awaiting the beginning of the trial, and I will send out specific inclusion/exclusion criteria with a flyer and more as soon as we receive final approval. More to come soon!
_____________________
David Darrow, MD MPH
Department of Neurosurgery
University of Minnesota
We are excited to get started and busy preparing. Once we have IRB approval, we will send out specific information about how to sign up for screening and how to refer patients. We will have an active presence on a new website, where the trial will be more clearly described.
I know that everyone is anxiously awaiting the beginning of the trial, and I will send out specific inclusion/exclusion criteria with a flyer and more as soon as we receive final approval. More to come soon!
_____________________
David Darrow, MD MPH
Department of Neurosurgery
University of Minnesota